logo

Lupin Ltd. Financials

15:59 Oct 29

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1955.90
+37.20 (+1.94%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1955.90
+37.20 (+1.94%)
15:59 Oct 29
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

34/100
Technically Bearish

Strength

14

Weakness

3

Opportunity

2

Threats

0

19.07 %

ROE %

11.23 %

ROA %

80.99

EPS

376.77

BVPS

14.45 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
16405.48 16641.66 20010.82 22707.9 23375.91
Operating Expenses +
16118.26 14843.54 16200.3 17424.59 17631.24
Raw Material
6679.56 6626.03 7100.91 7100.03 7154.31
Increase Decrease in Cost
-198.32 153.73 -457.44 -257.78 -284.69
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2989.3 3087.15 3494.57 3964.2 4076.16
Miscellaneous Expenses
13535.42 10853.07 11979.7 11903.38 6685.46
Operating Profit
287.22 1798.12 3810.52 5283.31 5744.67
Other Income
141.69 73.36 120.17 195.82 231.99
Depreciation
1658.71 880.69 1196.81 1169.26 1220.53
Interest
142.77 274.3 311.61 294.87 318.62
Profit before tax and exceptio..
-1372.57 716.49 2422.27 4015 4437.51
Exceptional Items
0 0 0 0 0
PBT
-1372.57 716.49 2422.27 4015 4437.51
Provision for Taxation
137.15 268.8 486.7 708.74 715.33
Net Profit
-1509.72 447.69 1935.57 3306.26 3722.18
NET Profit after MI
-1528.04 430.08 1914.48 3281.62 3699.34
EPS
-33.65 9.41 41.87 71.95 81.08
Operating Profit Margin (%)
1.75 10.8 19.04 23.27 24.58
Net Profit Margin (%)
-9.31 2.58 9.57 14.45 15.83

Lupin Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Sep 25 Jun 25 Mar 25 Dec 24 Sep 24
Promoter 46.90 46.90 46.90 47.00 47.00
FII 20.50 21.20 21.50 22.00 21.50
MF 20.60 19.40 17.60 16.90 16.90
Others 5.90 6.20 7.80 7.80 8.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: